Stockreport

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Grifols, S.A. - American Depositary Shares  (GRFS) 
Last grifols, s.a. - american depositary shares earnings: 5/7 07:27 am Check Earnings Report
PDF Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur musta [Read more]